Keros Therapeutics, Inc. (KROS)
10.78
-0.25
(-2.27%)
USD |
NASDAQ |
Aug 24, 16:00
10.79
+0.01
(+0.09%)
After-Hours: 20:00
Keros Therapeutics Market Cap : 213.74M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 213.74M |
| August 21, 2026 | 218.69M |
| August 20, 2026 | 217.11M |
| August 19, 2026 | 220.08M |
| August 18, 2026 | 210.37M |
| August 17, 2026 | 207.79M |
| August 14, 2026 | 200.25M |
| August 13, 2026 | 211.36M |
| August 12, 2026 | 222.06M |
| August 11, 2026 | 210.96M |
| August 10, 2026 | 211.95M |
| August 07, 2026 | 221.07M |
| August 06, 2026 | 211.16M |
| August 05, 2026 | 198.17M |
| August 04, 2026 | 203.23M |
| August 03, 2026 | 200.45M |
| July 31, 2026 | 199.66M |
| July 30, 2026 | 202.63M |
| July 29, 2026 | 196.74M |
| July 28, 2026 | 198.71M |
| July 27, 2026 | 201.47M |
| July 24, 2026 | 198.51M |
| July 23, 2026 | 200.09M |
| July 22, 2026 | 201.47M |
| July 21, 2026 | 208.58M |
| Date | Value |
|---|---|
| July 20, 2026 | 209.36M |
| July 17, 2026 | 209.96M |
| July 16, 2026 | 209.36M |
| July 15, 2026 | 217.65M |
| July 14, 2026 | 208.58M |
| July 13, 2026 | 219.03M |
| July 10, 2026 | 232.85M |
| July 09, 2026 | 237.39M |
| July 08, 2026 | 230.28M |
| July 07, 2026 | 229.89M |
| July 06, 2026 | 217.65M |
| July 02, 2026 | 222.19M |
| July 01, 2026 | 214.69M |
| June 30, 2026 | 211.14M |
| June 29, 2026 | 215.68M |
| June 26, 2026 | 216.86M |
| June 25, 2026 | 205.42M |
| June 24, 2026 | 215.48M |
| June 23, 2026 | 217.06M |
| June 22, 2026 | 216.67M |
| June 18, 2026 | 210.15M |
| June 17, 2026 | 205.42M |
| June 16, 2026 | 197.92M |
| June 15, 2026 | 202.06M |
| June 12, 2026 | 200.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 25.72B |
| Nurix Therapeutics, Inc. | 2.724B |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
| Anika Therapeutics, Inc. | 285.59M |
Market Cap Related Metrics
| PS Ratio | 19.25 |
| Price to Book Value | 0.8148 |
| Price | 10.78 |
| Earnings Yield | -34.32% |